Abstract
Hyperammonemia occurs mainly in patients with branched-chain organic acidemias such as propionic, methylmalonic, and isovaleric acidemias. Its pathophysiological process is mainly via the competitive inhibition of N-acetylglutamate synthetase. Oral carglumic acid (N-carbamylglutamate) administration can correct hyperammonemia in neonates with propionic and methylmalonic acidemias, thus avoiding dialysis therapy. Isovaleric acidemia is an autosomal recessive disease of leucine metabolism due to deficiency of isovaleryl-CoA dehydrogenase. For the first time, we report a neonate with isovaleric acidemia, whose plasma ammonia concentration dropped dramatically after one oral load of carglumic acid. This experience suggests that carglumic acid could be considered for acute hyperammonemia resulting from isovaleric acidemia. However, trials with more patients are needed.
Similar content being viewed by others
References
Castorina M, Rigante D, Antuzzi D, Sciascia Cannizzaro G, Ricci R (2008) Different outcome in isovaleric acidemia might be related to unsatisfactory diet compliance. Scand J Gastroenterol 43(6):767–768
Ensenauer R, Vockley J, Willard JM et al (2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75(6):1136–1142
Filippi L, Gozzini E, Fiorini P, Malvagia S, la Marca G, Donati MA (2010) N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology 97(3):286–290
Gebhardt B, Dittrich S, Parbel S, Vlaho S, Matsika O, Bohles H (2005) N-carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia. J Inherit Metab Dis 28(2):241–244
Jones S, Reed CA, Vijay S, Walter JH, Morris AA (2008) N-Carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia. J Inherit Metab Dis (in press)
Schwahn BC, Pieterse L, Bisset WM, Galloway PG, Robinson PH (2010) Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia. Eur J Pediatr 169(1):133–134
Shigematsu Y, Hata I, Tajima G (2010) Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria. J Inherit Metab Dis 33(Suppl 2):S283–288
Shigematsu Y, Hata I, Tanaka Y (2007) Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. Clin Chim Acta 386(1–2):82–86
Sogut A, Acun C, Aydin K, Tomac N, Demirel F, Aktuoglu C (2004) Isovaleric acidaemia: cranial CT and MRI findings. Pediatr Radiol 34(2):160–162
Vockley J, Ensenauer R (2006) Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet 142C(2):95–103
Conflict of interest
The authors have no financial conflict of interest to report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasapkara, C.S., Ezgu, F.S., Okur, I. et al. N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia. Eur J Pediatr 170, 799–801 (2011). https://doi.org/10.1007/s00431-010-1362-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-010-1362-9